Drug Database
Back to search

Netherlands· NL-683c5e1a593f

Relestat, oogdruppels, oplossing 0,5 mg/ml

A epinastine product containing epinastinehydrochloride, registered in Netherlands by AbbVie B.V.. The same ATC class is registered in 8 of our 19 countries.

ATC S01GX10

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedRelestat, oogdruppels, oplossing 0,5 …ATCS01GX10REGISTER NO.NL-683c5e1a593fPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about epinastinehydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Epinastine is registered in 8 of 19 countries.

Countries holding a registration under ATC S01GX10 (epinastine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 5 of them publish a price we can compare per daily dose
Search epinastine products by name

Epinastine · ATC S01GX10

8 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Ireland
  • Netherlands
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
EPINASTINEHYDROCHLORIDE
Manufacturer
AbbVie B.V.
Country
Netherlands (NL)
ATC code
S01GX10
ATC class
Epinastine
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    28710

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Epinastine in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All epinastine products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Belgium · Relestat
  • Czechia · Purivist
  • France · Purivist
  • United Kingdom (Northern Ireland) · Relestat
  • Greece · Optallerg, Relestat
  • Hungary · Relestat
  • Ireland · Relestat
  • Italy · Relestat
  • Luxembourg · Relestat
  • Portugal · Relestat
  • Sweden · Relestat
  • Slovakia · Purivist

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3ad0f255-5106-44eb-8435-005d0d735fd4
GET /v1/drugs/3ad0f255-5106-44eb-8435-005d0d735fd4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oogdruppels, oplossing",
  "route": "Oculair gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h28710_smpc.pdf",
  "strength": null,
  "atc_label": "Epinastine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg28710",
  "excipients": [
    "BENZALKONIUMCHLORIDE",
    "DINATRIUMEDETAAT 2-WATER",
    "NATRIUMCHLORIDE",
    "NATRIUMDIWATERSTOFFOSFAAT 2-WATER (E 339)",
    "NATRIUMHYDROXIDE (E 524)",
    "WATER, GEZUIVERD",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "EPINASTINEHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h28710.pdf",
  "authorised_at": "2003/10/27",
  "procedure_number": "SE/H/0315/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "28710",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about epinastine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console